Cigna Group $CI Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its position in shares of Cigna Group (NYSE:CI) by 7.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,901,749 shares of the health services provider’s stock after selling 876,723 shares during the quarter. Cigna Group makes up about 1.0% of Massachusetts Financial Services Co. MA’s portfolio, making the stock its 13th biggest holding. Massachusetts Financial Services Co. MA owned 4.08% of Cigna Group worth $3,142,429,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Pathway Financial Advisers LLC increased its holdings in Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after buying an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. increased its stake in shares of Cigna Group by 17.7% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after purchasing an additional 34 shares in the last quarter. HM Payson & Co. raised its holdings in Cigna Group by 0.9% in the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares during the period. Carr Financial Group Corp boosted its position in Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after purchasing an additional 36 shares in the last quarter. Finally, Natural Investments LLC grew its holdings in Cigna Group by 2.0% in the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 36 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CI shares. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Sunday, December 28th. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price target on shares of Cigna Group in a report on Tuesday, January 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a report on Friday, October 31st. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $330.48.

Cigna Group Trading Down 2.0%

CI opened at $272.29 on Friday. The firm has a market capitalization of $72.74 billion, a price-to-earnings ratio of 12.01, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company’s 50 day simple moving average is $273.63 and its two-hundred day simple moving average is $287.08. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter last year, the firm earned $7.51 earnings per share. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were issued a $1.51 dividend. The ex-dividend date of this dividend was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.64%.

Insider Transactions at Cigna Group

In other news, CEO David Cordani bought 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.